These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19250834)

  • 21. Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.
    Reyes CP; Muñoz-Martínez F; Torrecillas IR; Mendoza CR; Gamarro F; Bazzocchi IL; Núñez MJ; Pardo L; Castanys S; Campillo M; Jiménez IA
    J Med Chem; 2007 Oct; 50(20):4808-17. PubMed ID: 17850057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of interactions between uracil-based hybrid molecules and P-glycoprotein--search for multidrug resistance modulators.
    Singh P; Paul K
    Bioorg Med Chem; 2006 Nov; 14(21):7183-6. PubMed ID: 16843673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing macrocyclic diterpenes as multidrug-resistance reversers: structure-activity studies on jolkinol D derivatives.
    Reis M; Ferreira RJ; Santos MM; dos Santos DJ; Molnár J; Ferreira MJ
    J Med Chem; 2013 Feb; 56(3):748-60. PubMed ID: 23336337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.
    Chiba P; Holzer W; Landau M; Bechmann G; Lorenz K; Plagens B; Hitzler M; Richter E; Ecker G
    J Med Chem; 1998 Oct; 41(21):4001-11. PubMed ID: 9767638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids.
    Jain S; Laphookhieo S; Shi Z; Fu LW; Akiyama S; Chen ZS; Youssef DT; van Soest RW; El Sayed KA
    J Nat Prod; 2007 Jun; 70(6):928-31. PubMed ID: 17488128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Paradiso A
    Bioorg Med Chem; 2008 Apr; 16(7):3732-43. PubMed ID: 18276145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lathyrane diterpenes from Euphorbia lathyris as modulators of multidrug resistance and their crystal structures.
    Jiao W; Dong W; Li Z; Deng M; Lu R
    Bioorg Med Chem; 2009 Jul; 17(13):4786-92. PubMed ID: 19443229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study.
    Jara GE; Vera DM; Pierini AB
    J Mol Graph Model; 2013 Nov; 46():10-21. PubMed ID: 24095875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells.
    de Ravel MR; Alameh G; Melikian M; Mahiout Z; Emptoz-Bonneton A; Matera EL; Lomberget T; Barret R; Rocheblave L; Walchshofer N; Beltran S; El Jawad L; Mappus E; Grenot C; Pugeat M; Dumontet C; Le Borgne M; Cuilleron CY
    J Med Chem; 2015 Feb; 58(4):1832-45. PubMed ID: 25634041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
    Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
    Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities.
    Mehdipour AR; Javidnia K; Hemmateenejad B; Amirghofran Z; Miri R
    Chem Biol Drug Des; 2007 Oct; 70(4):337-46. PubMed ID: 17937779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression.
    Guglielmo S; Contino M; Lazzarato L; Perrone MG; Blangetti M; Fruttero R; Colabufo NA
    ChemMedChem; 2016 Feb; 11(4):374-6. PubMed ID: 26797828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).
    Labrie P; Maddaford SP; Lacroix J; Catalano C; Lee DK; Rakhit S; Gaudreault RC
    Bioorg Med Chem; 2007 Jun; 15(11):3854-68. PubMed ID: 17399990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.
    Gadhe CG; Madhavan T; Kothandan G; Cho SJ
    BMC Struct Biol; 2011 Jan; 11():5. PubMed ID: 21269449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of an optimized positional scanning library of peptoids: identification of novel multidrug resistance reversal agents.
    Masip I; Cortés N; Abad MJ; Guardiola M; Pérez-Payá E; Ferragut J; Ferrer-Montiel A; Messeguer A
    Bioorg Med Chem; 2005 Mar; 13(6):1923-9. PubMed ID: 15727848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors.
    Martelli C; Alderighi D; Coronnello M; Dei S; Frosini M; Le Bozec B; Manetti D; Neri A; Romanelli MN; Salerno M; Scapecchi S; Mini E; Sgaragli G; Teodori E
    J Med Chem; 2009 Feb; 52(3):807-17. PubMed ID: 19140665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective hydroboration of dieneamines. Formation of hydroxyalkylphenothiazines as MDR modulators.
    Takács D; Nagy I; Bombicz P; Egyed O; Jemnitz K; Riedl Z; Molnár J; Amaral L; Hajós G
    Bioorg Med Chem; 2012 Jul; 20(14):4258-70. PubMed ID: 22739092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
    Zhao Y; Bu L; Yan H; Jia W
    Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450.
    Labrie P; Maddaford SP; Lacroix J; Catalano C; Lee DK; Rakhit S; Gaudreault RC
    Bioorg Med Chem; 2006 Dec; 14(23):7972-87. PubMed ID: 16904325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators.
    Barile E; Borriello M; Di Pietro A; Doreau A; Fattorusso C; Fattorusso E; Lanzotti V
    Org Biomol Chem; 2008 May; 6(10):1756-62. PubMed ID: 18452010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.